• Blog
  • News
  • 90 years of HA
  • Career
  • Eng
    • Fra
    • CN
    • KR
  • About us

    About us

    • Company & Values
    • History
    • Executive leadership
    • Production department
    • CSR Commitments
    • International Presence
    • Latest Investments
    • Compliance
  • Biopolymers portfolio
  • Premium Services
  • Innovation & R&D
  • Excellence in Quality
  • Industrial Platform
  • Contact
Articles February 16, 2026

Lunar New Year 2026: Entering the Year of the Fire Horse

From 17 February, we celebrate the Lunar New Year and step into the Year of the Fire Horse — a powerful symbol of drive, resilience, and forward momentum across Asia.
A time of renewal, ambition, and fresh opportunities for growth.

Read the article Close and continue
Home - News

Read our news

Dive into the latest updates and happenings at HTL Biotechnology

Choix de la catégorie
  • Articles February 16, 2026

    Lunar New Year 2026: Entering the Year of the Fire Horse

    From 17 February, we celebrate the Lunar New Year and step into the Year of the Fire Horse — a powerful symbol of drive, resilience, and forward momentum across Asia.
    A time of renewal, ambition, and fresh opportunities for growth.

    Read more
  • Articles February 1, 2026

    HTL Biotechnology at IMCAS 2026: advancing the future of regenerative medicine

    HTL Biotechnology took part in IMCAS 2026, one of the leading international congresses dedicated to aesthetic medicine and dermatology. This major event was an opportunity to highlight the company’s strategy, innovations, and commitment to advancing regenerative medicine through high-performance biopolymers.

    Read more
  • Articles December 12, 2025

    HTL Biotechnology joins the Choiseul Conquérants 2025 ranking

    HTL Biotechnology is recognized for the second consecutive year among France’s most dynamic and innovative mid-sized companies.

    Read more
  • Articles October 29, 2025

    HTL Inside Webinar: a success that boosts our visibility in Asia

    On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.

    Read more
  • Articles October 9, 2025

    HTL Biotechnology rallies for Pink October 2025

    This October, HTL Biotechnology turned pink to support breast cancer prevention.

    Read more
  • Articles September 19, 2025

    HTL Biotechnology wins the Responsible Care 2025 Award

    HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.

    Read more
  • Articles September 13, 2025

    Looking Back at Our Presence at ESCRS 2025

    The European Society of Cataract and Refractive Surgeons (ESCRS) is a unique opportunity each year to connect with our clients and partners while gaining insights into the key trends shaping the future of ophthalmology.

    Read more
  • Articles July 23, 2025

    2024 CSR Report is now available!

    We’re pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.

    Read more
  • Articles June 12, 2025

    Strong Presence at ISHAS Congress 2025 in the USA

    A Global Scientific Gathering Dedicated to Hyaluronic Acid Innovation.

    Read more
  • Press releases June 5, 2025

    HTL Biotechnology inaugurates a new production line dedicated to sterile hyaluronic acid

    As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.

    Read more
  • Press releases May 27, 2025

    HTL Biotechnology supports National Biomedicines manufacturing Day

    HTL Biotechnology is proud to support National Biomedicines manufacturing Day, which will take place on June 5, 2025.

    Read more
  • Articles April 2, 2025

    François Fournier Featured in Korean Press

    HTL Biotechnology CEO François Fournier spoke to leading Korean media DongA Ilbo, reaffirming Korea’s strategic importance and the strong, long-standing ties with Korean customers.

    Read more
Learn more
  • Company & Values
  • History
  • Biopolymers portfolio
  • Innovation & R&D
  • Production department
  • Career
Contact us

Find us on social media

Social Media Group Policy

  • Terms & Conditions of Sale
  • Legal Notice & GTC
  • Privacy Policy
  • Cookies Policy
  • Sitemap

© HTL, 2024. All rights reserved